Li Y-R, Shen X, Zhu Y, Li Z, Hon R, Tian Y, Huang J, Zhao A. S., Ma N. Y., zhang C, Lin D, Sargsyan K, Yuan Y, and Yang L. Targeting Triple-negative breast cancer using cord-blood CD34+ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity. J Hematol Oncol. 2025 October 13;18(1):86. doi: 10.1186/s13045-025-01736-9. [Journal of Hematology & Oncology PDF][UCLA News PDF][UCLA Health News PDF][Public Now PDF]
